These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2548431)

  • 61. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a simple, effective and cheap procedure for percutaneous ablation.
    Giorgio A
    J Gastrointestin Liver Dis; 2010 Dec; 19(4):461-2. PubMed ID: 21188343
    [No Abstract]   [Full Text] [Related]  

  • 62. Resection of hepatocellular carcinoma arising from primary biliary cirrhosis.
    Nakahira A; Kubo S; Yamamoto T; Ogawa M; Sakabe K; Tanaka S; Uenishi T; Shuto T; Tanaka H; Hirohashi K
    J Gastroenterol; 2004; 39(3):302-3. PubMed ID: 15065012
    [No Abstract]   [Full Text] [Related]  

  • 63. Hepatocellular Carcinoma: The Current Role of Surgical Intervention.
    Colquhoun SD
    Crit Rev Oncog; 2016; 21(1-2):93-103. PubMed ID: 27481006
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical features in histologically proven primary hepatoma.
    Nicholson GD
    West Indian Med J; 1975 Jun; 24(2):97-101. PubMed ID: 171858
    [No Abstract]   [Full Text] [Related]  

  • 65. Cirrhosis and the aetiology of hepatocellular carcinoma.
    Johnson PJ; Williams R
    J Hepatol; 1987 Feb; 4(1):140-7. PubMed ID: 3033058
    [No Abstract]   [Full Text] [Related]  

  • 66. [A case of double cancer of hepatocellular carcinoma and mucoepidermoid carcinoma of the liver with cirrhosis].
    Minami R; Morita S; Inui A; Oimomi T; Kasuga M; Satonaka K; Maeda S
    Nihon Shokakibyo Gakkai Zasshi; 1992 May; 89(5):1314-8. PubMed ID: 1320144
    [No Abstract]   [Full Text] [Related]  

  • 67. Hepatocellular carcinoma with cardiac cirrhosis.
    Ho SS; Brown R; Fitzgibbon B
    Med J Aust; 1990 May; 152(10):553-4. PubMed ID: 2160048
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Use of silicon-impregnated compresses for echographic detection of section planes during hepatectomies].
    Hasegawa H; de Cervens T; Yamamoto J
    Presse Med; 1992 Mar; 21(9):434-5. PubMed ID: 1314378
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autoimmune hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).
    Trivedi PJ; Cullen S
    Dig Dis Sci; 2011 Feb; 56(2):276-8. PubMed ID: 21127980
    [No Abstract]   [Full Text] [Related]  

  • 70. [Prospective study of the development of hepatocellular carcinoma in 160 patients with cirrhosis of the liver].
    Oka H; Kurioka N; Kim K; Kanno T; Harihara S; Yamamoto S; Monna T
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2145-50. PubMed ID: 3029471
    [No Abstract]   [Full Text] [Related]  

  • 71. Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?
    Braillon A
    Cancer; 2015 Apr; 121(7):1149-50. PubMed ID: 25470258
    [No Abstract]   [Full Text] [Related]  

  • 72. Merging epidemiological changes and surveillance data to optimize management of hepatocellular carcinoma.
    Cillo U
    Dig Liver Dis; 2011 Nov; 43(11):841-2. PubMed ID: 21908240
    [No Abstract]   [Full Text] [Related]  

  • 73. Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?
    Flemming JA; Kim WR; Terrault NA
    Cancer; 2015 Apr; 121(7):1150. PubMed ID: 25470366
    [No Abstract]   [Full Text] [Related]  

  • 74. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?
    Anagnostopoulos GK; Arvanitidis D; Tsiakos S; Margantinis G; Grigoriadis K; Kostopoulos P
    J Clin Gastroenterol; 2003 Jul; 37(1):88-9. PubMed ID: 12811221
    [No Abstract]   [Full Text] [Related]  

  • 75. Risk factors in development of liver carcinoma in cirrhosis.
    Bjørneboe M
    Lancet; 1985 Sep; 2(8455):611-2. PubMed ID: 2863618
    [No Abstract]   [Full Text] [Related]  

  • 76. Risk factors and hepatocellular cancer.
    Yu MC; Henderson BE
    Lancet; 1985 Aug; 2(8450):329-30. PubMed ID: 2862491
    [No Abstract]   [Full Text] [Related]  

  • 77. Hepatocellular carcinoma in cystic fibrosis liver disease: a cautionary tale.
    O'Brien C; Ramlaul N; Haughey A; Nolan N; Malone DE; McCormick PA
    QJM; 2019 Sep; 112(9):693-694. PubMed ID: 31214693
    [No Abstract]   [Full Text] [Related]  

  • 78. Etiologic factors and clinical presentation of hepatocellular carcinoma: differences between cirrhotic and noncirrhotic Italian patients.
    Nzeako UC
    Cancer; 1995 Sep; 76(5):915. PubMed ID: 8625198
    [No Abstract]   [Full Text] [Related]  

  • 79. [Cirrhosis and its complications].
    Oumrani S; Parlier D
    Rev Infirm; 2015 Jan; (207):22-4. PubMed ID: 26144510
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Statistical analysis of prognosis in liver cirrhosis with reference to prediction of the high risk group for hepatocellular carcinoma].
    Hanyuda Y
    Nihon Ika Daigaku Zasshi; 1988 Jun; 55(3):279-90. PubMed ID: 2841351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.